1. Home
  2. DNLI vs BRC Comparison

DNLI vs BRC Comparison

Compare DNLI & BRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • BRC
  • Stock Information
  • Founded
  • DNLI 2013
  • BRC 1914
  • Country
  • DNLI United States
  • BRC United States
  • Employees
  • DNLI N/A
  • BRC N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • BRC Miscellaneous manufacturing industries
  • Sector
  • DNLI Health Care
  • BRC Consumer Discretionary
  • Exchange
  • DNLI Nasdaq
  • BRC Nasdaq
  • Market Cap
  • DNLI 3.3B
  • BRC 3.6B
  • IPO Year
  • DNLI 2017
  • BRC 1984
  • Fundamental
  • Price
  • DNLI $21.43
  • BRC $74.36
  • Analyst Decision
  • DNLI Strong Buy
  • BRC Strong Buy
  • Analyst Count
  • DNLI 11
  • BRC 1
  • Target Price
  • DNLI $40.40
  • BRC $65.00
  • AVG Volume (30 Days)
  • DNLI 815.8K
  • BRC 285.5K
  • Earning Date
  • DNLI 11-06-2024
  • BRC 11-18-2024
  • Dividend Yield
  • DNLI N/A
  • BRC 1.28%
  • EPS Growth
  • DNLI N/A
  • BRC 10.43
  • EPS
  • DNLI N/A
  • BRC 4.05
  • Revenue
  • DNLI N/A
  • BRC $1,386,475,000.00
  • Revenue This Year
  • DNLI N/A
  • BRC $14.14
  • Revenue Next Year
  • DNLI $420.35
  • BRC $4.25
  • P/E Ratio
  • DNLI N/A
  • BRC $18.49
  • Revenue Growth
  • DNLI 204.74
  • BRC 3.37
  • 52 Week Low
  • DNLI $14.56
  • BRC $56.09
  • 52 Week High
  • DNLI $33.33
  • BRC $77.68
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 31.13
  • BRC 53.69
  • Support Level
  • DNLI $22.61
  • BRC $74.70
  • Resistance Level
  • DNLI $24.15
  • BRC $77.00
  • Average True Range (ATR)
  • DNLI 1.09
  • BRC 1.36
  • MACD
  • DNLI -0.15
  • BRC 0.08
  • Stochastic Oscillator
  • DNLI 7.59
  • BRC 57.98

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About BRC Brady Corporation

Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.

Share on Social Networks: